Since the withdrawal of Vioxx, issues surrounding drug safety, adverse events and pharmacovigilance have become more important than ever, leading to a plethora of debate and discussion regarding drug safety issues. The fine balance between benefit and risk means that there are many differing opinions from experts spanning different disciplines including pharmacology, clinical medicine, pharmacoeconomics and regulatory affairs.
Over the last year, Expert Opinion on Drug Safety has seen an increase in the amount of feedback received. To accommodate this, the journal has launched a correspondence section, in which readers can address issues arising from reviews published in the journal. This correspondence section also allows the author to reply, thus stimulating interesting debate - an important forum for discussion. All letters published in the correspondence section are freely available online.
(PS: Some OA is better than no OA. But do OA letters to the editor deserve a press release?)
Posted by
Peter Suber at 1/06/2006 10:24:00 PM.
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
